Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 65862-721

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 65862-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rabeprazole Fig1

The text provides mean scores for different treatments on heartburn among a sample of 68 people on placebo, 64 people on RAB 10mg, and 67 people on RAB 20mg. The heartburn scores are rated on a scale of 0 to 4, with 0 indicating no heartburn, and 4 indicating very severe heartburn. This information can be useful for evaluating the effectiveness of these treatments in reducing heartburn symptoms.*

FDA Label Image

Figure 2: Mean Daytime Heartburn Scores Rab-usa-2 (Rabeprazole Fig2)

This text appears to be a report or data summary from a study about the effectiveness of a placebo and two different doses of a medication called RAB in reducing heartburn symptoms. The number of participants in each group is given (n=64 for RAB10mg and n=67 for RAB20mg). The heartburn scores are also mentioned, with 0 indicating no heartburn and 1-4 indicating increasing severity. The scores were recorded on study days 7, 14, 21, and 28.*

FDA Label Image

Figure 3: Mean Nighttime Heartburn Scores Rab-usa-2 (Rabeprazole Fig3)

This text presents mean score data for a study comparing a placebo group to a group taking RAB 20mg. The study included 58 participants in the placebo group and 59 in the RAB 20mg group. The study looks at heartburn scores on different days and categorizes them as None, Slight, Moderate, Severe, and Very Severe.*

FDA Label Image

Figure 4: Mean Daytime Heartburn Scores Rab-usa-3 (Rabeprazole Fig4)

This appears to be a chart or table showing heartburn scores for a study comparing a placebo to a medication called RAB20mg. The scores range from 0 to 4, with 0 indicating no heartburn and 4 indicating very severe heartburn. However, there is not enough context to provide more detail on the study or its significance.*

FDA Label Image

Figure 5: Mean Nighttime Heartburn Scores Rab-usa-3 (Rabeprazole Fig5)

This is a description of Rabeprazole Sodium delayed-release tablets. Each tablet has 20mg of Rabeprazole sodium USP, and the recommended dosage is stated in the accompanying prescribing information. Pharmacists are to give each patient a medication guide. The tablets come in a bottle of 30 and should be stored at room temperature, protected from moisture. The distributor of the medication is Aurobindo Pharma USA, Inc., and the medication was made in India. The NDC for the medication is 65862-721-30.*

FDA Label Image

Chemical Structure (Rabeprazole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.